Dynamics of replication origin over-activation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 17 11 2020
accepted: 19 05 2021
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 16 6 2021
Statut: epublish

Résumé

Safeguards against excess DNA replication are often dysregulated in cancer, and driving cancer cells towards over-replication is a promising therapeutic strategy. We determined DNA synthesis patterns in cancer cells undergoing partial genome re-replication due to perturbed regulatory interactions (re-replicating cells). These cells exhibited slow replication, increased frequency of replication initiation events, and a skewed initiation pattern that preferentially reactivated early-replicating origins. Unlike in cells exposed to replication stress, which activated a novel group of hitherto unutilized (dormant) replication origins, the preferred re-replicating origins arose from the same pool of potential origins as those activated during normal growth. Mechanistically, the skewed initiation pattern reflected a disproportionate distribution of pre-replication complexes on distinct regions of licensed chromatin prior to replication. This distinct pattern suggests that circumventing the strong inhibitory interactions that normally prevent excess DNA synthesis can occur via at least two pathways, each activating a distinct set of replication origins.

Identifiants

pubmed: 34103496
doi: 10.1038/s41467-021-23835-0
pii: 10.1038/s41467-021-23835-0
pmc: PMC8187443
doi:

Substances chimiques

CDT1 protein, human 0
Cell Cycle Proteins 0
Cyclopentanes 0
Pyrimidines 0
pevonedistat S3AZD8D215

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3448

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC010411
Pays : United States

Références

Petropoulos, M., Champeris Tsaniras, S., Taraviras, S. & Lygerou, Z. Replication licensing aberrations, replication stress, and genomic instability. Trends Biochem. Sci. 44, 752–764 (2019).
pubmed: 31054805 doi: 10.1016/j.tibs.2019.03.011
Techer, H., Koundrioukoff, S., Nicolas, A. & Debatisse, M. The impact of replication stress on replication dynamics and DNA damage in vertebrate cells. Nat. Rev. Genet. 18, 535–550 (2017).
Flach, J. et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512, 198–202 (2014).
pubmed: 25079315 pmcid: 4456040 doi: 10.1038/nature13619
Liontos, M. et al. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res. 67, 10899–10909 (2007).
pubmed: 18006835 doi: 10.1158/0008-5472.CAN-07-2837
Parker, M. W., Botchan, M. R. & Berger, J. M. Mechanisms and regulation of DNA replication initiation in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 52, 107–144 (2017).
pubmed: 28094588 pmcid: 5545932 doi: 10.1080/10409238.2016.1274717
Symeonidou, I. E. et al. Multi-step loading of human minichromosome maintenance proteins in live human cells. J. Biol. Chem. 288, 35852–35867 (2013).
pubmed: 24158436 pmcid: 3861635 doi: 10.1074/jbc.M113.474825
Parker, M. W. et al. A new class of disordered elements controls DNA replication through initiator self-assembly. Elife 8, e48562 (2019).
Ekundayo, B. & Bleichert, F. Origins of DNA replication. PLoS Genet. 15, e1008320 (2019).
pubmed: 31513569 pmcid: 6742236 doi: 10.1371/journal.pgen.1008320
Coleman, K. E. et al. Sequential replication-coupled destruction at G1/S ensures genome stability. Genes Dev. 29, 1734–1746 (2015).
pubmed: 26272819 pmcid: 4561482 doi: 10.1101/gad.263731.115
Walter, D. et al. SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication. Nat. Commun. 7, 10530 (2016).
pubmed: 26818844 pmcid: 4738361 doi: 10.1038/ncomms10530
Arias, E. E. & Walter, J. C. Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts. Genes Dev. 19, 114–126 (2005).
pubmed: 15598982 pmcid: 540230 doi: 10.1101/gad.1255805
Li, A. & Blow, J. J. Cdt1 downregulation by proteolysis and geminin inhibition prevents DNA re-replication in Xenopus. EMBO J. 24, 395–404 (2005).
pubmed: 15616577 doi: 10.1038/sj.emboj.7600520
Smith, O. K. et al. Distinct epigenetic features of differentiation-regulated replication origins. Epigenetics Chromatin 9, 18 (2016).
pubmed: 27168766 pmcid: 4862150 doi: 10.1186/s13072-016-0067-3
Prioleau, M. N. & MacAlpine, D. M. DNA replication origins-where do we begin? Genes Dev. 30, 1683–1697 (2016).
pubmed: 27542827 pmcid: 5002974 doi: 10.1101/gad.285114.116
Ganier, O., Prorok, P., Akerman, I. & Mechali, M. Metazoan DNA replication origins. Curr. Opin. Cell Biol. 58, 134–141 (2019).
pubmed: 31200185 doi: 10.1016/j.ceb.2019.03.003
Lombrana, R. et al. High-resolution analysis of DNA synthesis start sites and nucleosome architecture at efficient mammalian replication origins. EMBO J. 32, 2631–2644 (2013).
pubmed: 23995398 pmcid: 3791372 doi: 10.1038/emboj.2013.195
Aladjem, M. I. & Redon, C. E. Order from clutter: selective interactions at mammalian replication origins. Nat. Rev. Genet. 18, 101–116 (2017).
pubmed: 27867195 doi: 10.1038/nrg.2016.141
Alver, R. C., Chadha, G. S. & Blow, J. J. The contribution of dormant origins to genome stability: from cell biology to human genetics. DNA Repair (Amst.) 19, 182–189 (2014).
doi: 10.1016/j.dnarep.2014.03.012
Blow, J. J., Ge, X. Q. & Jackson, D. A. How dormant origins promote complete genome replication. Trends Biochem. Sci. 36, 405–414 (2011).
pubmed: 21641805 pmcid: 3329722 doi: 10.1016/j.tibs.2011.05.002
Shima, N. & Pederson, K. D. Dormant origins as a built-in safeguard in eukaryotic DNA replication against genome instability and disease development. DNA Repair (Amst.) 56, 166–173 (2017).
doi: 10.1016/j.dnarep.2017.06.019
Vaziri, C. et al. A p53-dependent checkpoint pathway prevents rereplication. Mol. Cell 11, 997–1008 (2003).
Zhang, Y. et al. A replicator-specific binding protein essential for site-specific initiation of DNA replication in mammalian cells. Nat. Commun. 7, 11748 (2016).
pubmed: 27272143 pmcid: 4899857 doi: 10.1038/ncomms11748
Jang, S. M. et al. The replication initiation determinant protein (RepID) modulates replication by recruiting CUL4 to chromatin. Nat. Commun. 9, 2782 (2018).
pubmed: 30018425 pmcid: 6050238 doi: 10.1038/s41467-018-05177-6
Fu, H. et al. Methylation of histone H3 on lysine 79 associates with a group of replication origins and helps limit DNA replication once per cell cycle. PLoS Genet. 9, e1003542 (2013).
pubmed: 23754963 pmcid: 3674996 doi: 10.1371/journal.pgen.1003542
Milhollen, M. A. et al. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res. 71, 3042–3051 (2011).
pubmed: 21487042 doi: 10.1158/0008-5472.CAN-10-2122
Lin, J. J., Milhollen, M. A., Smith, P. G., Narayanan, U. & Dutta, A. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res. 70, 10310–10320 (2010).
pubmed: 21159650 pmcid: 3059213 doi: 10.1158/0008-5472.CAN-10-2062
Petrakis, T. G. et al. Exploring and exploiting the systemic effects of deregulated replication licensing. Semin Cancer Biol. 37-38, 3–15 (2016).
pubmed: 26707000 doi: 10.1016/j.semcancer.2015.12.002
Best, S. et al. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells. Blood Adv. 3, 51–62 (2019).
pubmed: 30617217 pmcid: 6325297 doi: 10.1182/bloodadvances.2018026880
Vanderdys, V. et al. The neddylation inhibitor pevonedistat (MLN4924) suppresses and radiosensitizes head and neck squamous carcinoma cells and tumors. Mol. Cancer Ther. 17, 368–380 (2018).
pubmed: 28838998 doi: 10.1158/1535-7163.MCT-17-0083
Blank, J. L. et al. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. Cancer Res. 73, 225–234 (2013).
pubmed: 23100467 doi: 10.1158/0008-5472.CAN-12-1729
Yoshimura, C. et al. TAS4464, a highly potent and selective inhibitor of NEDD8-activating enzyme, suppresses neddylation and shows antitumor activity in diverse cancer models. Mol. Cancer Ther. 18, 1205–1216 (2019).
pubmed: 31092565 doi: 10.1158/1535-7163.MCT-18-0644
McIntosh, D. & Blow, J. J. Dormant origins, the licensing checkpoint, and the response to replicative stresses. Cold Spring Harb Perspect Biol 4, a012955 (2012).
Klotz-Noack, K., McIntosh, D., Schurch, N., Pratt, N. & Blow, J. J. Re-replication induced by geminin depletion occurs from G2 and is enhanced by checkpoint activation. J. Cell Sci. 125, 2436–2445 (2012).
pubmed: 22366459
Varma, D. et al. Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required for stable kinetochore-microtubule attachment. Nat. Cell Biol. 14, 593–603 (2012).
pubmed: 22581055 pmcid: 3366049 doi: 10.1038/ncb2489
Pozo, P. N. & Cook, J. G. Regulation and function of Cdt1; a key factor in cell proliferation and genome stability. Genes (Basel) 8, 2 (2016).
Fu, H. et al. The DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous damage. Nat. Commun. 6, 6746 (2015).
pubmed: 25879486 doi: 10.1038/ncomms7746
Neelsen, K. J. et al. Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template. Genes Dev. 27, 2537–2542 (2013).
pubmed: 24298053 pmcid: 3861667 doi: 10.1101/gad.226373.113
Davidson, I. F., Li, A. & Blow, J. J. Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision. Mol. Cell 24, 433–443 (2006).
pubmed: 17081992 pmcid: 1819398 doi: 10.1016/j.molcel.2006.09.010
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A. & Jeyasekharan, A. D. ROS and the DNA damage response in cancer. Redox Biol. 25, 101084 (2019).
pubmed: 30612957 doi: 10.1016/j.redox.2018.101084
Campisi, J. & d’Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729–740 (2007).
pubmed: 17667954 doi: 10.1038/nrm2233
Meselson, M. & Stahl, F. W. The replication of DNA in Escherichia Coli. Proc. Natl Acad. Sci. USA 44, 671–682 (1958).
pubmed: 16590258 doi: 10.1073/pnas.44.7.671 pmcid: 528642
Menzel, J., Tatman, P. & Black, J. C. Isolation and analysis of rereplicated DNA by Rerep-Seq. Nucleic Acids Res. 48, e58 (2020).
pubmed: 32239215 pmcid: 7261181 doi: 10.1093/nar/gkaa197
Rao, S. S. P. et al. Cohesin loss eliminates all loop domains. Cell 171, 305–320 (2017). e324.
pubmed: 28985562 pmcid: 5846482 doi: 10.1016/j.cell.2017.09.026
Fu, H. et al. Mapping replication origin sequences in eukaryotic chromosomes. Curr. Protoc. Cell Biol. 65, 22 20 21-17 (2014).
doi: 10.1002/0471143030.cb2220s65
Martin, M. M. et al. Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res. 21, 1822–1832 (2011).
pubmed: 21813623 pmcid: 3205567 doi: 10.1101/gr.124644.111
Pongor, L. S. et al. BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks. Epigenetics Chromatin 13, 21 (2020).
pubmed: 32321568 pmcid: 7175505 doi: 10.1186/s13072-020-00343-x
Utani, K. et al. Phosphorylated SIRT1 associates with replication origins to prevent excess replication initiation and preserve genomic stability. Nucleic Acids Res. 45, 7807–7824 (2017).
pubmed: 28549174 pmcid: 5570034 doi: 10.1093/nar/gkx468
Koren, A. et al. Genetic variation in human DNA replication timing. Cell 159, 1015–1026 (2014).
pubmed: 25416942 pmcid: 4359889 doi: 10.1016/j.cell.2014.10.025
Mukhopadhyay, R. et al. Allele-specific genome-wide profiling in human primary erythroblasts reveal replication program organization. PLoS Genet. 10, e1004319 (2014).
pubmed: 24787348 pmcid: 4006724 doi: 10.1371/journal.pgen.1004319
Das, S. P. et al. Replication timing is regulated by the number of MCMs loaded at origins. Genome Res. 25, 1886–1892 (2015).
pubmed: 26359232 pmcid: 4665009 doi: 10.1101/gr.195305.115
Dellino, G. I. et al. Genome-wide mapping of human DNA-replication origins: levels of transcription at ORC1 sites regulate origin selection and replication timing. Genome Res. 23, 1–11 (2013).
pubmed: 23187890 pmcid: 3530669 doi: 10.1101/gr.142331.112
Miotto, B., Ji, Z. & Struhl, K. Selectivity of ORC binding sites and the relation to replication timing, fragile sites, and deletions in cancers. Proc. Natl Acad. Sci. USA 113, E4810–E4819 (2016).
pubmed: 27436900 doi: 10.1073/pnas.1609060113 pmcid: 4995967
Nishitani, H. et al. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25, 1126–1136 (2006).
pubmed: 16482215 pmcid: 1409712 doi: 10.1038/sj.emboj.7601002
Kelly, T. & Callegari, A. J. Dynamics of DNA replication in a eukaryotic cell. Proc. Natl Acad. Sci. USA 116, 4973–4982 (2019).
pubmed: 30718387 doi: 10.1073/pnas.1818680116 pmcid: 6421431
Ullah, Z., Lee, C. Y., Lilly, M. A. & DePamphilis, M. L. Developmentally programmed endoreduplication in animals. Cell Cycle 8, 1501–1509 (2009).
pubmed: 19372757 doi: 10.4161/cc.8.10.8325
Aymard, F. et al. Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genes. Nat. Struct. Mol. Biol. 24, 353–361 (2017).
pubmed: 28263325 pmcid: 5385132 doi: 10.1038/nsmb.3387
Clouaire, T. et al. Comprehensive mapping of histone modifications at DNA double-strand breaks deciphers repair pathway chromatin signatures. Mol. Cell 72, 250–262 (2018). e256.
pubmed: 30270107 pmcid: 6202423 doi: 10.1016/j.molcel.2018.08.020
Finn, K. J. & Li, J. J. Single-stranded annealing induced by re-initiation of replication origins provides a novel and efficient mechanism for generating copy number expansion via non-allelic homologous recombination. PLoS Genet. 9, e1003192 (2013).
pubmed: 23300490 pmcid: 3536649 doi: 10.1371/journal.pgen.1003192
Abbas, T., Keaton, M. A. & Dutta, A. Genomic instability in cancer. Cold Spring Harb. Perspect. Biol. 5, a012914 (2013).
pubmed: 23335075 pmcid: 3578360 doi: 10.1101/cshperspect.a012914
Abbas, T. & Dutta, A. Regulation of mammalian DNA replication via the ubiquitin-proteasome system. Adv. Exp. Med. Biol. 1042, 421–454 (2017).
pubmed: 29357069 pmcid: 5933532 doi: 10.1007/978-981-10-6955-0_19
Havens, C. G. & Walter, J. C. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev. 25, 1568–1582 (2011).
pubmed: 21828267 pmcid: 3182024 doi: 10.1101/gad.2068611
Hayashi, A. et al. Direct binding of Cdt2 to PCNA is important for targeting the CRL4(Cdt2) E3 ligase activity to Cdt1. Life Sci. Alliance 1, e201800238 (2018).
pubmed: 30623174 pmcid: 6312923 doi: 10.26508/lsa.201800238
Zhu, W. & Depamphilis, M. L. Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 69, 4870–4877 (2009).
pubmed: 19487297 pmcid: 2749580 doi: 10.1158/0008-5472.CAN-08-4559
Machida, Y. J. & Dutta, A. The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 21, 184–194 (2007).
pubmed: 17234884 pmcid: 1770901 doi: 10.1101/gad.1495007
Anglana, M., Apiou, F., Bensimon, A. & Debatisse, M. Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. Cell 114, 385–394 (2003).
pubmed: 12914702 doi: 10.1016/S0092-8674(03)00569-5
Moiseeva, T. N. et al. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proc. Natl Acad. Sci. USA 116, 13374–13383 (2019).
pubmed: 31209037 doi: 10.1073/pnas.1903418116 pmcid: 6613105
Irony-Tur Sinai, M. & Kerem, B. Genomic instability in fragile sites-still adding the pieces. Genes Chromosomes Cancer 58, 295–304 (2019).
pubmed: 30525255 doi: 10.1002/gcc.22715
Alvarez, S. et al. Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality. Nat. Commun. 6, 8548 (2015).
pubmed: 26456157 doi: 10.1038/ncomms9548
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
pubmed: 24695404 pmcid: 4103590 doi: 10.1093/bioinformatics/btu170
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234 doi: 10.1093/bioinformatics/btp324
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 18798982 pmcid: 2592715 doi: 10.1186/gb-2008-9-9-r137
Layer, R. M. et al. GIGGLE: a search engine for large-scale integrated genome analysis. Nat. Methods 15, 123–126 (2018).
pubmed: 29309061 pmcid: 5872823 doi: 10.1038/nmeth.4556
Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187–W191 (2014).
pubmed: 24799436 pmcid: 4086134 doi: 10.1093/nar/gku365
Durand, N. C. et al. Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments. Cell Syst. 3, 95–98 (2016).
pubmed: 27467249 pmcid: 5846465 doi: 10.1016/j.cels.2016.07.002

Auteurs

Haiqing Fu (H)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Christophe E Redon (CE)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Bhushan L Thakur (BL)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Koichi Utani (K)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Department of Microbiology, Kanazawa Medical University, Uchinada Ishikawa, Kanazawa, Japan.

Robin Sebastian (R)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Sang-Min Jang (SM)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Department of Biochemistry, Chungbuk National University, Chungdae-ro, Seowon-gu, Cheongju, Korea.

Jacob M Gross (JM)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Sara Mosavarpour (S)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Anna B Marks (AB)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Sophie Z Zhuang (SZ)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Sarah B Lazar (SB)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Mishal Rao (M)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Shira T Mencer (ST)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Adrian M Baris (AM)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Program in Cancer Biology, Oregon Health and Science University, Portland, OR, USA.

Lorinc S Pongor (LS)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Mirit I Aladjem (MI)

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. aladjemm@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH